Abstract
Deep learning approaches for clinical predictions based on magnetic resonance imaging data have shown great promise as a translational technology for diagnosis and prognosis in neurological disorders, but its clinical impact has been limited. This is partially attributed to the opaqueness of deep learning models, causing insufficient understanding of what underlies their decisions. To overcome this, we trained convolutional neural networks on structural brain scans to differentiate dementia patients from healthy controls, and applied layerwise relevance propagation to procure individual-level explanations of the model predictions. Through extensive validations we demonstrate that deviations recognized by the model corroborate existing knowledge of structural brain aberrations in dementia. By employing the explainable dementia classifier in a longitudinal dataset of patients with mild cognitive impairment, we show that the spatially rich explanations complement the model prediction when forecasting transition to dementia and help characterize the biological manifestation of disease in the individual brain. Overall, our work exemplifies the clinical potential of explainable artificial intelligence in precision medicine.
Competing Interest Statement
KP report work with Roche BN29553 and Novo Nordisk NN6535-4730 trials; All other authors declare that they have no competing interests.
Funding Statement
This work was funded by the UiO:LifeScience Convergence Environment (project: 4MENT), the Research Council of Norway (302854), and the European Research Council under the European Union's Horizon 2020 research and Innovation program (802998). The Southern and Eastern Norway Regional Health Authority supported the study through funding for KP but was not involved in conducting the study or in preparation of the manuscript. TW acknowledges funding from the German Research Foundation (DFG) Emmy Noether: 513851350.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The dataset was compiled from various sources, the most important being: ADNI: https://adni.loni.usc.edu/ AIBL: http://www.aibl.csiro.au/ MIRIAD: https://www.nitrc.org/projects/miriad/ OASIS3: https://www.oasis-brains.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Updated title to be more precise, minor text updates
Data Availability
The raw data incorporated in this work were gathered from various resources. Material requests will need to be placed with individual principal investigators. A detailed overview of the independent datasets, and their origins, is provided in the supplementary information.